BROUGHT TO YOU BY:

ETF Portfolio Builder

New

ETF Portfolio Builder

New

BMEDvsIHEETF Comparison

ETF 1

BMED

iShares Health Innovation Active ETF

This fund is part of

Healthcare Technology

-1.76%

Full BMED fund page

VS

ETF 2

IHE

iShares U.S. Pharmaceuticals ETF

This fund is part of

US Health Care

-0.99%

Full IHE fund page

iShares Health Innovation Active ETF (BMED) belongs to the Healthcare Technology segment. iShares U.S. Pharmaceuticals ETF (IHE) is part of the US Health Care segment. Both ETFs have the same top 2 sector exposures: Healthcare and Non-Corporate. BMED is more expensive with a Total Expense Ratio (TER) of 0.77%, versus 0.37% for IHE. BMED is up 14.51% year-to-date (YTD) with +$5M in YTD flows. IHE performs better with 20.34% YTD performance, and +$520M in YTD flows. Run a side-by-side ETF comparison of BMED and IHE below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios. Discover our library of Model portfolios

BMED vs IHE performance and flow charts

Performance

Cumulative Flows

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Data Services

Historic performance and flows

Data as of 10/16/2026

		1M	3M	YTD	1Y	3Y	5Y
Perf.	BMED IHE	+3.05%-0.08%	+12.16%+1.23%	+14.51%+20.34%	+24.44%+38.40%	+54.98%+74.98%	+20.00%+80.77%
Flows	BMED IHE	--$84M	+$1M+$92M	+$5M+$520M	+$6M+$684M	+$7M+$778M	+$6M+$784M

Volatility and drawdown

		3M	1Y	3Y	5Y
Volatility	BMED IHE	+21.82%+17.96%	+17.81%+18.23%	+16.86%+17.17%	+18.13%+16.70%
Max drawdown	BMED IHE	-5.85%-9.67%	-14.71%-9.67%	-19.76%-16.04%	-32.14%-16.12%
Max drawdown duration	BMED IHE	31d58d	196d58d	237d210d	1479d669d

Trading data

Create an account to view trading data

Join for free

	BMED	IHE
Last sale 10/16/2026 at 6:23 PM	$34.55	$100.64
Previous close 10/16/2026	$35.06	$101.06
Consolidated volume 10/16/2026
Average volume 30 days
Average discount or premium 30 days
Average Bid/Ask spread 30 days

Replication quality

Data as of September 30, 2026

1-year trailing difference

Create an account to view replication metrics

Join for free

BMED

is actively managed and doesn’t replicate an index

Create an account to view replication quality

Join for free

	BMED	IHE
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst

Main metrics

Last update 10/16/2026 at 6:23 PM

Live

Closed

	BMED	IHE
Last price	$34.55	$100.64
1D performance	-1.45%	-0.42%
AuM	$13.83 M	$1.54 B
E/R	0.77%	0.37%

Characteristics

	BMED	IHE
Management strategy	Active	Passive
Provider	iShares	iShares
Benchmark	-	Dow Jones U.S. Select Pharmaceuticals Index
N° of holdings	53	57
Asset class	-	Equities
Trailing 12m distribution yield	Join	Join
Inception date	September 29, 2020	May 1, 2006
ESG	No	No

More BMED data on Trackinsight

More IHE data on Trackinsight

Exposure

Countries

BMED

USA

87.23%

Other

12.77%

IHE

USA

95.75%

Other

4.25%

Sectors

BMED

Healthcare

98.95%

Other

1.05%

IHE

Healthcare

99.75%

Other

0.25%

Diversification

BMED

Total weight of top 15 holdings out of 15

58.7%

IHE

Total weight of top 15 holdings out of 15

84.42%

Top 15 holdings

Data as of August 31, 2026

BMED

Gilead Sciences, Inc.

5.01%

Merck & Co., Inc.

4.99%

AbbVie, Inc.

4.61%

Johnson & Johnson

4.27%

Charles River Laboratories International, Inc.

4.22%

Thermo Fisher Scientific, Inc.

4.12%

Edwards Lifesciences Corp.

3.95%

Moderna, Inc.

3.86%

IQVIA Holdings, Inc.

3.72%

Danaher Corp.

3.64%

Vertex Pharmaceuticals, Inc.

3.56%

Waters Corp.

3.53%

Biogen, Inc.

3.45%

Mettler-Toledo International, Inc.

3.16%

DexCom, Inc.

2.61%

IHE

Johnson & Johnson

22.45%

Eli Lilly & Co.

20.50%

Merck & Co., Inc.

5.00%

Bristol Myers Squibb Co.

4.84%

Royalty Pharma Plc

4.54%

Pfizer Inc.

4.48%

Viatris, Inc.

4.19%

Zoetis, Inc.

3.82%

Jazz Pharmaceuticals Plc

3.43%

Elanco Animal Health, Inc.

2.61%

Corcept Therapeutics, Inc.

2.36%

Crinetics Pharmaceuticals, Inc.

1.95%

Axsome Therapeutics, Inc.

1.87%

Ligand Pharmaceuticals, Inc.

1.24%

Definium Therapeutics, Inc.

1.12%

Frequently asked questions about BMED and IHE

How have the BMED and IHE ETFs performed in 2026?

As of October 16, 2026, BMED is up 14.51% year-to-date (YTD), while IHE has returned 20.34%. That puts IHE better performer ahead so far this year.

Which ETF is attracting more investor money: BMED or IHE?

Year-to-date, the BMED ETF saw +$5M in flows, compared to +$520M for IHE.

Which ETF is more volatile: BMED or IHE?

Over the past year, BMED had a volatility of 17.81%, while IHE experienced 18.23%.

Which ETF is bigger: BMED or IHE?

As of October 16, 2026, BMED holds $13.83 M in assets under management (AUM), while IHE manages $1.54 B.

What sectors do the BMED and IHE ETFs invest in?

BMED leans toward sectors like Healthcare. Meanwhile, IHE focuses on Healthcare.

What are the top holdings of the BMED ETF and IHE ETF?

BMED top holdings include Gilead Sciences, Inc., Merck & Co., Inc. and AbbVie, Inc.. IHE holds in its top three: Johnson & Johnson, Eli Lilly & Co. and Merck & Co., Inc..

BMEDvsIHEETF Comparison

iShares Health Innovation Active ETF

iShares U.S. Pharmaceuticals ETF

BMED vs IHE performance and flow charts

Performance

Cumulative Flows

Get all the metrics on this page, and more, through a reliable ETF data feed

Countries

Sectors

Diversification

Top 15 holdings

How have the BMED and IHE ETFs performed in 2026?

As of October 16, 2026, BMED is up 14.51% year-to-date (YTD), while IHE has returned 20.34%. That puts IHE better performer ahead so far this year.

Which ETF is attracting more investor money: BMED or IHE?

Year-to-date, the BMED ETF saw +$5M in flows, compared to +$520M for IHE.

Which ETF is more volatile: BMED or IHE?

Over the past year, BMED had a volatility of 17.81%, while IHE experienced 18.23%.

Which ETF is bigger: BMED or IHE?

As of October 16, 2026, BMED holds $13.83 M in assets under management (AUM), while IHE manages $1.54 B.

What sectors do the BMED and IHE ETFs invest in?

BMED leans toward sectors like Healthcare. Meanwhile, IHE focuses on Healthcare.

What are the top holdings of the BMED ETF and IHE ETF?

BMED top holdings include Gilead Sciences, Inc., Merck & Co., Inc. and AbbVie, Inc.. IHE holds in its top three: Johnson & Johnson, Eli Lilly & Co. and Merck & Co., Inc..

Which ETF is more diversified: BMED or IHE?

BMED holds 55 securities with 58.7% of its assets in the top 15. IHE has 57 securities and a top 15 weight of 84.42%.

Analyzing the Potential ETF Winners & Losers from The Weight-Loss Drug Craze

Healthcare Stocks Rebound

Health is Wealth: A look at the Healthcare Sector

ETFs’ Next Act: From Access to Selection